Kevin Jefferson, DPM
Podiatrist · Washington, DCNPI 1811080229
Payments from drug & device makers
What this record shows
This record is dominated by other: $87,200 of the $94,387 with a category attached, or 92.4%. Convatec Inc. accounts for 92.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $88,593 and has fallen 97.4% since, to $2,260 in 2025. Among podiatrist clinicians in DC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $1137.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$87K
- Triad Life Sciences Inc.$2K
- Lifenet Health$2K
- Smith+Nephew$857
- Treace Medical Concepts, Inc.$843
- Paratek Pharmaceuticals, Inc.$325
- plus $436 from 9 others
What the payments were for
- Travel & lodging$4,9525%
- Food & beverage$2,2352%
- Other$87,20092%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 7 | $87,244 |
| Triad Life Sciences Inc. | 4 | $2,429 |
| Lifenet Health | 11 | $2,253 |
| Smith+Nephew | 34 | $857 |
| Treace Medical Concepts, Inc. | 3 | $843 |
| Paratek Pharmaceuticals, Inc. | 11 | $325 |
| GSK | 1 | $116 |
| Organogenesis Inc. | 3 | $68 |
| Zimmer Biomet | 1 | $61 |
| Amgen(2 entities) | 3 | $55 |
| Supreme Orthopedic Systems, LLC | 1 | $45 |
| Baxter Healthcare | 1 | $33 |
| Averitas Pharma Inc. | 1 | $21 |
| Novum Pharma, LLC | 1 | $21 |
| Kerecis Limited | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$89,549
- TheraGenesis Wound Matrix$1,942
- Lapiplasty$680
- Santyl$241
- REGRANEX$119
- Oasis$119
- NUZYRA$117
- NUCALA$116
How this compares
$94,387 in reported general payments places this provider in the 95th percentile of 24 podiatrist providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 51 | $2,938 |
| Ketoconazole | 63 | $2,680 |
| Ammonium Lactate | 54 | $1,717 |
| Terbinafine Hcl | 46 | $987 |
| Econazole Nitrate | 19 | $781 |
| CiclopiroxCiclopirox Olamine | 25 | $496 |
| Mupirocin | 16 | $215 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $69 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Washington
- Michael StempelWashington$5K
- Nadav AvnerWashington$4K
- Farah SiddiquiWashington$2K
- Ian BeiserWashington$2K
- Lee FirestoneWashington$2K
- Kirk GeterWashington$1K
- Arnold RavickWashington$1K
- Sheldon LapsWashington$1K
- Lubrina BryantWashington$951
- James GirolamiWashington$718
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.